Endothelin modulates the pressor actions of acute systemic nitric oxide blockade.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of the American Society of Nephrology

• Publication date

  1995-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8589326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats.

  1995cited by this paper
• Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.

  1995cited by this paper
• Actions of endogenous endothelin on glomerular hemodynamics in the rat.

  1995cited by this paper
• Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

  1994cited by this paper
• Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells.

  1994cited by this paper
• Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.

  1994cited by this paper
• Termination of endothelin signaling: Role of nitric oxide

  1994cited by this paper
• Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.

  1994cited by this paper
• Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.

  1993cited by this paper
• Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.

  1993cited by this paper
• Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

  1993cited by this paper
• Endothelin‐converting enzymes

  1992cited by this paper
• Molecular characterization of endothelin receptors.

  1992cited by this paper
• Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide.

  1992cited by this paper
• Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells.

  1992cited by this paper
• Inhibition of Endothelium‐Derived Relaxing Factor Enhances Endothelin‐Mediated Vasoconstriction

  1992cited by this paper
• Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition.

  1992cited by this paper
• Endothelin inhibits fluid and bicarbonate transport in part by reducing Na+/K+ ATPase activity in the rat proximal straight tubule.

  1991cited by this paper
• Endothelium-derived vasoactive factors and the renal vasculature.

  1991cited by this paper
• Endothelium‐Derived Relaxing Factor Modulates Endothelin Action in Afferent Arterioles

  1991cited by this paper
• Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1.

  1991cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Role of endogenous endothelin in renal function during altered sodium balance.

  1991cited by this paper
• Renal effects of administered atrial natriuretic peptide in the conscious, aging rat.

  1990cited by this paper
• Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.

  1990cited by this paper
• Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.

  1990cited by this paper
• Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney.

  1990cited by this paper
• Cloning and expression of a cDNA encoding an endothelin receptor

  1990cited by this paper
• Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells.

  1990cited by this paper
• Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

  1990cited by this paper
• Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells.

  1989cited by this paper
• Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

  1988cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Angiotensin II inhibition on blood pressure and renal hemodynamics in pregnant rats.

  1986cited by this paper
• Renal hemodynamics in conscious rats: effects of anesthesia, surgery, and recovery.

  1983cited by this paper
• THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

  1945cited by this paper

• in rats with normal renal function Uremic levels of BUN do not cause nitric oxide deficiency

  2016cites this paper
• during low- and high-intensity contractions 2 andV?o modulation of skeletal muscle blood flow

  2015cites this paper
• Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.

  2015cites this paper
• Acute nitric oxide synthase inhibition and endothelin-1-dependent arterial pressure elevation

  2014cites this paper
• The Renal Circulations and Glomerular Ultrafiltration

  2012cites this paper
• Role of endothelin‐1 in the hyper‐responsiveness to nitrovasodilators following acute NOS inhibition

  2012cites this paper
• Identification of Cathepsin L as a Potential Sex-Specific Biomarker for Renal Damage

  2011cites this paper
• Selective Inhibition of Protein Kinase C β2 Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats

  2009cites this paper
• Zelltypspezifische Interaktion zwischen Endothelin und dem NO-System: Verteilungsmuster der ET-1-Expression in mit L-NAME behandelten Nieren von präpro-ET-1-LacZ-transgenen Mäusen

  2008cites this paper
• Zelltypspezifische Interaktion zwischen Endothelin und dem NO-System : Verteilungsmuster der ET-1-Expression in mit L-NAME behandelten Nieren von präpro-ET-1-LacZ-transgenen Mäusen

  2008cites this paper
• Endogenous nitric oxide reduces the efficacy of the endothelin system to maintain blood pressure during high epidural anaesthesia in conscious dogs

  2007cites this paper
• The endocrine system in chronic nitric oxide deficiency.

  2007cites this paper
• Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade.

  2007cites this paper
• The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats

  2006cites this paper
• Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by α1-adrenoceptor antagonism

  2005cites this paper
• Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit.

  2004influential citation
• Emerging role of relaxin in renal and cardiovascular function.

  2004cites this paper
• Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects

  2003cites this paper
• Chronic Endothelin Receptor Blockade Prevents Both Early Hyperfiltration and Late Overt Diabetic Nephropathy in the Rat

  2003cites this paper
• Effects of dopamine and nitric oxide on arterial pressure and renal function in volume expansion

  2002cites this paper
• Upregulation of vascular renin-angiotensin and endothelin systems in rats inhibited of nitric oxide synthesis.

  2002cites this paper
• Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.

  2002cites this paper
• Endothelial modulation of skeletal muscle blood flow and VO(2) during low- and high-intensity contractions.

  2002cites this paper
• Endothelin Mediates Some of the Renal Actions of Acutely Administered Angiotensin II

  2001cites this paper
• Endothelin Mediates the Altered Renal Hemodynamics Associated with Experimental Congestive Heart Failure

  2001cites this paper
• Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat.

  2001influential citation
• Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibition in anesthetized dogs.

  2001cites this paper
• The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.

  2001cites this paper
• Effects Of L‐Arginine And Furosemide On Blood Pressure And Renal Function In Volume‐Expanded Rats

  2001cites this paper
• Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function.

  2001cites this paper
• Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.

  2001cites this paper
• Endothelin and Its Inhibitors

  2001cites this paper
• ENDOTHELIN AND BLOOD PRESSURE REGULATION IN THE FEMALE RAT: STUDIES IN NORMAL PREGNANCY AND WITH NITRIC OXIDE SYNTHASE INHIBITION-INDUCED HYPERTENSION

  2000cites this paper
• [Endothelium and hypertension].

  2000cites this paper
• Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II.

  2000cites this paper
• Alterations of vascular endothelial nitric oxide synthase activity and substrate availability in chronic renal disease

  1999cites this paper
• Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition.

  1999cites this paper
• Pressor and renal vasoconstrictor responses to acute systemic nitric oxide synthesis inhibition are independent of the sympathetic nervous system and angiotensin II.

  1999cites this paper
• State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension.

  1999cites this paper
• CHRONIC STUDIES ON THE INTERACTION BETWEEN NITRIC OXIDE AND ENDOTHELIN IN CARDIOVASCULAR AND RENAL FUNCTION

  1999cites this paper
• Effect of endothelin blockade on pressure natriuresis in nitric oxide-deficient hypertensive rats.

  1999cites this paper
• Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition

  1999influential citation
• Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.

  1999cites this paper
• Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass.

  1999cites this paper
• ACUTE INTERACTIONS BETWEEN ENDOTHELIN AND NITRIC OXIDE IN THE CONTROL OF RENAL HAEMODYNAMICS

  1999cites this paper
• Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension.

  1998cites this paper
• Low Nitric Oxide Production in Patients with Chronic Renal Failure

  1998cites this paper
• Endothelial dysfunction in acute renal failure

  1998cites this paper
• Endothelin in hypertension: a role for receptor antagonists?

  1998cites this paper
• Chronic nitric oxide inhibition model six years on.

  1998cites this paper
• Mechanisms of Hypertension in the Chronic NOS Inhibition Model

  1998cites this paper
• Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.

  1998cites this paper
• Nitric oxide synthase inhibition increases vascular resistance in sodium and water loaded rats

  1998cites this paper
• The role of endothelin in the age dependent increase in renal vascular resistance in the rat kidney.

  1998cites this paper
• Endothelin-A receptor antagonist combined with hydralazine improves survival and renal function in hypertensive rats.

  1998cites this paper
• Nitric oxide, the kidney, and hypertension.

  1997cites this paper
• Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade.

  1997cites this paper
• Biosynthesis and homeostatic roles of nitric oxide in the normal kidney.

  1997cites this paper
• Physiological role of endothelin in cardiovascular and renal hemodynamics: studies in animals.

  1997cites this paper
• AT2‐antagonist sensitive potentiation of angiotensin II‐induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature

  1997cites this paper
• Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.

  1997cites this paper
• Enhancement of nitric oxide synthesis by L-arginine supplementation in renal disease: is it good or bad?

  1997cites this paper
• Importance of nitric oxide in the control of renal hemodynamics.

  1996cites this paper
• Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat

  1996cites this paper